Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

The randomized, controlled PALISADE trial demonstrated the benefit of daily oral immunotherapy with Peanut (Arachis Hypogaea) allergen powder-dnfp (PTAH, formerly AR101) in peanut-allergic children and adolescents.ARC004, the open-label follow-on study to PALISADE, used 5 dosing cohorts to explore P...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Brian P. Vickery, Andrea Vereda, Caroline Nilsson, George Du Toit, Wayne G. Shreffler, A. Wesley Burks, Stacie M. Jones, Montserrat Fernández‐Rivas, Katharina Blümchen, Jonathan O’B Hourihane, Kirsten Beyer, Aikaterini Anagnostou, Amal Assa’ad, Moshe Ben‐Shoshan, J. Andrew Bird, Tara F. Carr, Warner Carr, Thomas B. Casale, Hey Chong, Christina E. Ciaccio, Morna J. Dorsey, Stanley M. Fìneman, Stephen B. Fritz, Alexander N. Greiner, Leon S. Greos, Frank C. Hampel, María Ibáñez-Vea, David Jeong, Douglas Johnston, Rita Kachru, Edwin Kim, Bruce J. Lanser, Stephanie A. Leonard, Mary C. Maier, Lyndon E. Mansfield, Antonella Muraro, Jason Ohayon, J. N. G. Oude Elberink, Daniel Petroni, Jacqueline A. Pongracic, Jay M. Portnoy, Rima Rachid, Ned T. Rupp, Georgiana Sanders, Hemant Sharma, Vibha Sharma, Ellen Sher, Lawrence Sher, Sayantani Sindher, Dareen Siri, Jonathan M. Spergel, A. B. Sprikkelman, Gordon L. Sussman, Marina Tsoumani, Pooja Varshney, Girish Vitalpur, Julie Wang, William H. Yang, José Manuel Zubeldia, Alex Smith, Robert Ryan, Daniel C. Adelman
التنسيق:	Artigo
اللغة:	الإنجليزية
منشور في:	2020
الوصول للمادة أونلاين:	https://doi.org/10.1016/j.jaip.2020.12.029 http://www.jaci-inpractice.org/article/S2213219820313611/pdf
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

مواد مشابهة